147 related articles for article (PubMed ID: 29843022)
1. Investigating the target organs of novel anti-diabetic zinc complexes with organo‑selenium ligands.
Nishiguchi T; Yoshikawa Y; Yasui H
J Inorg Biochem; 2018 Aug; 185():103-112. PubMed ID: 29843022
[TBL] [Abstract][Full Text] [Related]
2. Anti-Diabetic Effect of Organo-Chalcogen (Sulfur and Selenium) Zinc Complexes with Hydroxy-Pyrone Derivatives on Leptin-Deficient Type 2 Diabetes Model ob/ob Mice.
Nishiguchi T; Yoshikawa Y; Yasui H
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29215553
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel antidiabetic zinc complex with an organoselenium ligand at the lowest dosage in KK-A(y) mice.
Fujimoto S; Yasui H; Yoshikawa Y
J Inorg Biochem; 2013 Apr; 121():10-5. PubMed ID: 23314593
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and pharmacokinetic studies of anti-diabetic tropolonato-Zn(II) complexes with Zn(S(2)O(2)) coordination mode.
Murakami H; Yasui H; Yoshikawa Y
Chem Pharm Bull (Tokyo); 2012; 60(9):1096-104. PubMed ID: 22976316
[TBL] [Abstract][Full Text] [Related]
5. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
6. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H
J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407
[TBL] [Abstract][Full Text] [Related]
7. Anti-hyperglycemic Effect of Long-Term Bis(hinokitiolato)zinc Complex ([Zn(hkt)
Naito Y; Yoshikawa Y; Shintani M; Kamoshida S; Kajiwara N; Yasui H
Biol Pharm Bull; 2017; 40(3):318-326. PubMed ID: 28250273
[TBL] [Abstract][Full Text] [Related]
8. Morphological analysis of the pancreas and liver in diabetic KK-A(y) mice treated with zinc and oxovanadium complexes.
Moroki T; Yoshikawa Y; Yoshizawa K; Tsubura A; Yasui H
Metallomics; 2014 Sep; 6(9):1632-8. PubMed ID: 24905743
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the insulin-like properties of zinc(II) complexes of 3-hydroxy-4-pyridinones: identification of a compound with glucose lowering effect in STZ-induced type I diabetic animals.
Moniz T; Amorim MJ; Ferreira R; Nunes A; Silva A; Queirós C; Leite A; Gameiro P; Sarmento B; Remião F; Yoshikawa Y; Sakurai H; Rangel M
J Inorg Biochem; 2011 Dec; 105(12):1675-82. PubMed ID: 22088976
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of Bis(aspirinato)zinc(II) complex ameliorates hyperglycemia and metabolic syndrome-like disorders in spontaneously diabetic KK-A(y) mice: structure-activity relationship on zinc-salicylate complexes.
Yoshikawa Y; Adachi Y; Yasui H; Hattori M; Sakurai H
Chem Pharm Bull (Tokyo); 2011; 59(8):972-7. PubMed ID: 21804241
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
Katoh A; Matsumura Y; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2009 Apr; 103(4):567-74. PubMed ID: 19162327
[TBL] [Abstract][Full Text] [Related]
12. A Family of [Zn
Majumder A; Dutta N; Dey S; Sow P; Samadder A; Vijaykumar G; Rangan K; Bera M
Inorg Chem; 2021 Dec; 60(23):17608-17626. PubMed ID: 34761905
[TBL] [Abstract][Full Text] [Related]
13. In vitro structure-specific Zn(II)-induced adipogenesis and structure-function bioreactivity correlations.
Halevas E; Tsave O; Yavropoulou M; Yovos JG; Hatzidimitriou A; Psycharis V; Salifoglou A
J Inorg Biochem; 2017 Dec; 177():228-246. PubMed ID: 29073545
[TBL] [Abstract][Full Text] [Related]
14. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice.
Saha TK; Yoshikawa Y; Sakurai H
ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806
[TBL] [Abstract][Full Text] [Related]
15. A new salicylic acid-derivatized kojic acid vanadyl complex: synthesis, characterization and anti-diabetic therapeutic potential.
Wei Y; Zhang C; Zhao P; Yang X; Wang K
J Inorg Biochem; 2011 Aug; 105(8):1081-5. PubMed ID: 21726771
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology of the insulinomimetic effect of zinc complexes.
Sakurai H; Adachi Y
Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, crystal structures and insulin-like activity of three new oxidovanadium(V) complexes with aroylhydrazone ligand.
Zhou QC; Wang TR; Li H; Chen L; Xin JJ; Guo S; Sheng GH; You ZL
J Inorg Biochem; 2019 Jul; 196():110680. PubMed ID: 30991187
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of bis(1,2-dimethyl-3-hydroxy-4-pyridinonato)oxidovanadium(IV), or VO(dmpp)2, on insulin secretion in pancreatic islets of type 2 diabetic Goto-Kakizaki rats.
Pelletier J; Domingues N; Castro MM; Östenson CG
J Inorg Biochem; 2016 Jan; 154():29-34. PubMed ID: 26559485
[TBL] [Abstract][Full Text] [Related]
19. Blood glucose lowering and toxicological effects of zinc (II) complexes with maltol, threonine, and picolinic acid.
Kojima Y; Yoshikawa Y; Ueda E; Kondo M; Takahashi S; Matsukura T; Sakurai H; Hiroi T; Imaoka S; Funae Y
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):91-104. PubMed ID: 15080500
[TBL] [Abstract][Full Text] [Related]
20. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.
Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y
J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
